Chemours Company (The) (NYSE:CC) Stake Lowered by Gotham Asset Management LLC

Gotham Asset Management LLC reduced its position in Chemours Company (The) (NYSE:CC) by 86.0% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 29,812 shares of the specialty chemicals company’s stock after selling 182,987 shares during the period. Gotham Asset Management LLC’s holdings in Chemours Company (The) were worth $1,130,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of CC. Stifel Financial Corp boosted its position in Chemours Company (The) by 6.3% in the 1st quarter. Stifel Financial Corp now owns 19,401 shares of the specialty chemicals company’s stock valued at $749,000 after buying an additional 1,146 shares during the last quarter. Schroder Investment Management Group acquired a new stake in shares of Chemours Company (The) in the 1st quarter valued at about $156,000. Neuberger Berman Group LLC raised its stake in shares of Chemours Company (The) by 1.5% in the 1st quarter. Neuberger Berman Group LLC now owns 9,579 shares of the specialty chemicals company’s stock valued at $369,000 after purchasing an additional 141 shares in the last quarter. Credit Agricole S A acquired a new stake in shares of Chemours Company (The) in the 1st quarter valued at about $910,000. Finally, Teachers Advisors LLC raised its stake in shares of Chemours Company (The) by 3.3% in the 1st quarter. Teachers Advisors LLC now owns 319,341 shares of the specialty chemicals company’s stock valued at $12,295,000 after purchasing an additional 10,093 shares in the last quarter. 72.77% of the stock is owned by institutional investors.

In other Chemours Company (The) news, VP Amy Trojanowski sold 2,500 shares of Chemours Company (The) stock in a transaction on Friday, August 11th. The shares were sold at an average price of $46.03, for a total transaction of $115,075.00. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider E Bryan Snell sold 10,000 shares of Chemours Company (The) stock in a transaction on Friday, August 11th. The stock was sold at an average price of $46.24, for a total transaction of $462,400.00. The disclosure for this sale can be found here. In the last three months, insiders sold 77,142 shares of company stock valued at $3,953,265. 1.14% of the stock is currently owned by insiders.

WARNING: This piece was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece on another site, it was copied illegally and republished in violation of U.S. & international copyright law. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2017/10/27/gotham-asset-management-llc-lowers-stake-in-chemours-company-the-cc.html.

Shares of Chemours Company (NYSE CC) traded up 0.02% during midday trading on Friday, hitting $56.62. 141,114 shares of the company’s stock traded hands. Chemours Company has a 1-year low of $15.90 and a 1-year high of $58.08. The firm has a market capitalization of $10.46 billion, a price-to-earnings ratio of 37.05 and a beta of 3.59. The company has a 50 day moving average price of $52.88 and a 200 day moving average price of $45.07.

Chemours Company (The) (NYSE:CC) last posted its quarterly earnings results on Wednesday, August 2nd. The specialty chemicals company reported $0.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.85 by $0.02. Chemours Company (The) had a net margin of 4.96% and a return on equity of 122.97%. The business had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.49 billion. During the same quarter last year, the firm posted $0.27 EPS. Chemours Company (The)’s revenue was up 14.8% compared to the same quarter last year. Equities analysts anticipate that Chemours Company will post $3.57 earnings per share for the current year.

A number of equities research analysts have recently issued reports on CC shares. Argus restated a “buy” rating and issued a $55.00 target price (up previously from $50.00) on shares of Chemours Company (The) in a research note on Thursday, August 10th. BidaskClub upgraded shares of Chemours Company (The) from a “hold” rating to a “buy” rating in a research note on Thursday, August 24th. Citigroup Inc. increased their price objective on shares of Chemours Company (The) from $45.00 to $59.00 and gave the stock a “buy” rating in a research note on Friday, August 4th. Jefferies Group LLC increased their price objective on shares of Chemours Company (The) to $60.00 and gave the stock a “buy” rating in a research note on Thursday, August 3rd. Finally, Zacks Investment Research lowered shares of Chemours Company (The) from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 12th. Two research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $52.75.

Chemours Company (The) Profile

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins.

Institutional Ownership by Quarter for Chemours Company (The) (NYSE:CC)

Receive News & Ratings for Chemours Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply